Featured Top Story
Moderna is seeking Food and Drug Administration approval of its new shot, dubbed mFlusiva, as an option for people 50 and older.
From
To
Featured
Moderna is also expected to receive approval for its updated vaccine.
Featured Top Story
Moderna's COVID-19 vaccine, Spikevax, had more than $3 billion in sales last year.
Featured Top Story
With the Food and Drug Administration’s clearance, Pfizer and Moderna are set to begin shipping millions of doses.
Featured Top Story
The Health District received a shipment of Pfizer on Monday and Moderna on Tuesday.